The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

Medically reviewed by Kathleen Daly, MD Postpartum depression (PPD), sometimes called perinatal depression, is a type of ...

There's a lot to cover during a postpartum checkup. Here are some questions you'll want to ask and what you can expect.

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

The transition to parenthood brings profound changes for men, including shifts in identity, relationships and daily routines, alongside unexpected biological changes.

Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...

Journalist Jacqueline Mendelsohn experienced mood swings and random bouts of crying with her first child. "I remember bursting into tears as I brought my daughter home and walked through the ...

Sage Therapeutics, Inc. (Nasdaq: SAGE) saw its stock price soar by an impressive 33.87%, reaching $7.43 during Monday’s premarket trading session. The surge came on the heels of the company’s ...

The difference between baby blues and postpartum depression; plus symptoms, triggers, and why early diagnosis and treatment ...